Celldex Therapeutics Inc (CLDX)
37.74
-1.11
(-2.86%)
USD |
NASDAQ |
Apr 23, 16:00
37.77
+0.03
(+0.08%)
After-Hours: 20:00
Celldex Therapeutics Asset Impairment Charge (Quarterly)
Asset Impairment Charge (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Asset Impairment Charge (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
Date | Value |
---|---|
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
September 30, 2016 | -- |
Asset Impairment Charge Definition
Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.